In Vivo is part of Pharma Intelligence UK Limited
This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.
Vantia brings in £19mm with its Series A venture round
07 Sep 2011
Vantia (spin-off of Ferring Pharmaceuticals AS; urological and gynecological conditions) has raised £19mm ($38.4mm) through its Series A venture round from a group of investors, including lead backer MVM Life Science Partners, SV Life Sciences, and Novo AS.
Already a Biomedtracker subscriber?You have access to the full deal record through your subscription
Want to become a subscriber?Subscribers get more deal details, updates, deal financials and deal products.Questions?